Cardinal Health (CAH) and McKesson (MCK) are competing in U.S. pharmaceutical distribution, with CAH showing stronger recent earnings momentum despite underperforming the broader medical sector over the past six months. In fiscal Q4 2026, Cardinal Health reported a 6% revenue increase to $63.7 billion, a...
Cardinal Health reported its third quarter fiscal year 2026 results with total revenues reaching $60.9 billion, representing an 11% increase compared to the same period in fiscal year 2025. While GAAP diluted earnings per share dropped 20% to $1.69 and operating earnings fell 30% to...
Cardinal Health, Inc. reported third-quarter fiscal 2026 results that exceeded analyst expectations for earnings per share but fell short on revenue. The company's adjusted EPS reached $3.17, surpassing the Zacks Consensus Estimate of $2.80 by 13.2%, while GAAP EPS stood at $1.69 compared to $2.10...
Cardinal Health reported strong fiscal 2026 results, with revenue reaching USD 254.2 billion, representing a 14 percent year-over-year increase. The company also demonstrated significant improvements in profitability and cash generation, with GAAP diluted EPS rising 12 percent to USD 7.23 and operating cash flow surging...
On January 13, 2026, Cardinal Health raised its fiscal 2026 non-GAAP diluted earnings per share outlook to at least $10.00, expanding from a previous range of $9.65 to $9.85. The company cited strong performance across all five operating segments and signaled continued operational momentum ahead...
Cardinal Health (CAH) reported robust full-year earnings guidance for fiscal 2027 that exceeded analyst expectations, prompting an upgrade in its price target. While Q2 revenue of $63.67 billion missed the $65.03 billion consensus due to regulatory headwinds and lower drug prices, adjusted EPS of $2.60...
Cardinal Health shares closed at $224.95 on September 18, 2026, trading roughly 18.5% below the consensus analyst price target of $266.56. The company reported a strong fiscal 2026 performance driven by double-digit earnings growth across all five operating segments, supported by exceptional specialty growth, customer...
Jim Cramer highlighted Cardinal Health (CAH) as an 'absolute favorite' on Mad Money, citing its strategic shift from a commoditized distributor to a specialized player with growing exposure to higher-margin healthcare services and specialty pharmaceuticals. The company is outperforming peers like McKesson and Cencora by...
Shares of Cardinal Health, Inc. (NYSE:CAH) have received an average recommendation of 'Moderate Buy' from eighteen brokerages covering the firm, with fifteen analysts rating it a buy and three holding. The consensus one-year price target stands at $251.73. Recent analyst actions include TD Cowen lifting...
Florida Financial Advisors LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 21.0% during the first quarter, purchasing an additional 2,643 shares to reach a total of 15,203 shares valued at $3.21 million. This position represents approximately 0.8% of the firm's portfolio and ranks...
Assetmark Inc. increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 35.4% during the first quarter, purchasing an additional 27,631 shares to reach a total of 105,770 shares valued at $22.35 million. Several other institutional investors and hedge funds also adjusted their stakes in the...
Bleakley Financial Group LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH) during the first quarter, purchasing 20,619 shares valued at approximately $4.36 million. Other institutional investors, including Aventura Private Wealth and University of Texas Investment Management, also established or increased stakes, while Jones...
Cardinal Health (NYSE:CAH) received a 'strong-buy' rating upgrade from Wall Street Zen analysts, contrasting with a recent downgrade to 'hold' by Zacks Research. The stock maintains a consensus 'Moderate Buy' rating among fifteen analysts with a price target of $247.80, though Wells Fargo recently lowered...
IFM Investors Pty Ltd increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 14.6% during the first quarter, purchasing an additional 5,489 shares to hold a total of 42,962 shares valued at approximately $9.08 million. Several other institutional investors also adjusted their positions, with Jones...
Cardinal Health (NYSE:CAH) shares reached a new 52-week high, trading as high as $240.93 with a volume of over 1.9 million shares. The stock recently closed at $237.92, reflecting continued investor interest despite mixed analyst sentiment regarding the company's recent performance and future outlook. In...
The article evaluates Cardinal Health (CAH) and UnitedHealth Group (UNH) over a 12-month period starting May 29, 2025, comparing their performance against an earlier prediction that favored Cardinal Health. Although Cardinal Health was the initial recommendation, UnitedHealth outperformed in terms of total return, rising from...
Cardinal Health (CAH) is featured as the Investor's Business Daily Stock of the Day, highlighted for its strong technical momentum and positive business developments. The company, a major drug wholesaler serving pharmacies, hospitals, and clinics, recently raised its guidance for fiscal year 2026, projecting adjusted...
Jim Cramer highlighted Cardinal Health (CAH) as an 'absolute favorite' on Mad Money, citing its strategic shift from a commoditized distributor to a specialized player with growing exposure to higher-margin healthcare services and specialty pharmaceuticals. The company has outperformed peers like McKesson and Cencora by...
Cardinal Health (CAH) shares rose 7.3% following the company's latest earnings report, which featured an earnings per share (EPS) beat despite a slight miss in total revenue. The stock's performance is being bolstered by positive developments in its neonatal intensive care respiratory devices segment, a...
Cardinal Health's Disposable Instant Cold Pack is a single-use medical accessory designed for clinics, athletic trainers, and home users requiring immediate cold therapy without refrigeration. The product utilizes an endothermic reaction involving ammonium nitrate to generate cold within seconds of activation, offering a practical solution...
